Intrexon | XON - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Agenus USD 82.99M 2.3M 2025-12
Alaunos Therapeutics USD 843K 34K 2025-09
Amgen USD 20.89B 1.25B 2025-12
Anika Therapeutics USD 6.04M 1.31M 2025-12
Arrowhead Research USD 32.94M 15.26M 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Heron Therapeutics USD 8.99M 3.02M 2025-12
Incyte USD 1.63B 1.46B 2025-12
Intrexon USD 4.85M 3.12M 2024-06
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
Ligand Pharmaceuticals USD 3.24M 24.52M 2025-12
MacroGenics USD 4.79M 1.15M 2025-12
MannKind USD 9.03M 1.76M 2025-12
Merck USD 4.15B 102M 2025-09
Novartis USD 4.46B 99M 2025-12
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Thermo Fisher Scientific USD 3.62B 502M 2025-12
Veracyte USD 4.59M 916K 2025-12
Xencor USD 10.83M 1.75M 2025-12